S&P 500 Energy Sector SEC Filings — April 27, 2026

27-04-2026

A Paradise Acquisition Corp. intends to voluntarily delist its units (APADU), Class A ordinary shares (APAD), and rights (APADR) from Nasdaq on or about May 7, 2026, following the closing of its proposed Business Combination with Enhanced Ltd to form Enhanced Group Inc. The combined company plans to list its Class A common stock on the NYSE under the symbol 'ENHA' starting on or about May 8, 2026, subject to closing the merger and satisfying NYSE requirements. This delisting represents a short-term disruption in Nasdaq trading, offset by the anticipated upgrade to NYSE listing.

• ·Extraordinary general meeting upcoming in connection with Business Combination.
• ·Registration statement on Form S-4 filed with SEC, including proxy statement/prospectus.
• ·Forward-looking risks include Enhanced’s limited operating history, minimal revenue, regulatory scrutiny, and dependence on key personnel.

27-04-2026

The Real Brokerage Inc. (Real) announced a definitive agreement to acquire RE/MAX Holdings, Inc., combining Real's agent-first, technology-driven model with RE/MAX's global brand and network, resulting in a combined entity with over 180,000 agents. The transaction is expected to close in the second half of 2026, with both companies operating independently until then, enabling enhanced scale, technology integration, referral networks, and ancillary services. While the deal promises transformational growth, it carries risks including regulatory approvals, shareholder consent, integration challenges, and potential disruptions to business relationships.

• ·Virtual town hall scheduled for 1 pm EST on April 27, 2026
• ·Operations to continue separately and independently until closing
• ·Legal restrictions on creating materials related to the announcement

27-04-2026

Ligand Pharmaceuticals (LGND) to acquire XOMA Royalty Corporation (XOMA) for $39.00 per share in cash, totaling approximately $739 million equity value (14% premium to 30-day VWAP), plus one CVR per share for 75% of net proceeds from Janssen litigation. The deal adds over 120 assets including seven commercial products, expected to close Q3 2026 and be immediately accretive to Ligand's adjusted EPS; Ligand raised 2026 guidance to revenue $270-310M (from $245-285M), royalties $225-250M (from $200-225M), and adjusted EPS $8.50-9.50 (from $8.00-9.00), with Captisol ($35-40M) and contract revenue ($10-20M) unchanged. Supported by BVF Partners (21% owner) and management voting agreements.

• ·Transaction funded by Ligand cash and credit facility; Series X Preferred converts to common, Series A/B redeemed prior to close.
• ·Investor call held April 27, 2026 at 8:00 a.m. ET.
• ·XOMA Series X Convertible Preferred Stock to convert at fixed price prior to closing.

27-04-2026

The Real Brokerage Inc. (REAX) announced a definitive agreement to acquire RE/MAX Holdings, Inc. (RMAX) for an enterprise value of approximately $880 million, forming Real REMAX Group with pro forma 2025 revenue of $2.3 billion and Adjusted EBITDA of $157 million before synergies. The transaction is expected to be accretive to Real’s earnings and EBITDA margin in the first full year post-close, with $30 million in annual run-rate cost synergies primarily from shared services and technology efficiencies. Ownership will be approximately 59% Real shareholders and 41% RE/MAX shareholders, with closing anticipated in H2 2026.

• ·Transaction implies 7x fully synergized multiple of 2025 EBITDA for RE/MAX Holdings.
• ·RE/MAX Holdings shareholders elect 5.152 shares of Real REMAX Group or $13.80 cash per share, subject to $60-80M aggregate cash proration.
• ·Dave Liniger (38% voting power) and certain Real officers/directors (16% shares) committed to vote in favor.
• ·Combined 10-member board includes 3 from RE/MAX Holdings board; headquartered in Miami with Denver operations.
• ·Expected 100 basis points margin expansion from synergies once fully realized in 2027.
• ·Conference call today at 8:30am ET; Real Q1 2026 earnings May 7, 2026; RE/MAX Q1 cancelled.

27-04-2026

XOMA Royalty Corporation entered into a Merger Agreement with Ligand Pharmaceuticals Incorporated and Flex Merger Sub, Inc. on April 27, 2026, pursuant to which common stockholders will receive $39.00 per share in cash plus Contingent Value Rights tied to RemainCo LLC. The Company Board unanimously approved the transaction, deemed it fair and advisable, and recommended it to stockholders. The merger is subject to customary conditions including majority stockholder approval, HSR clearance, and completion of Holding Company Reorganization and CVR Spin, with no financing condition.

• ·Series X Convertible Preferred Stock converts to Merger Consideration based on underlying common shares.
• ·8.625% Series A and 8.375% Series B Perpetual Preferred Stock to be redeemed per certificates of designation, including accrued and unpaid dividends.
• ·Merger outside date: January 26, 2027.
• ·No-shop restrictions with fiduciary outs for Superior Proposals and Intervening Events.

27-04-2026

The Real Brokerage Inc. (REAX) announced its acquisition of RE/MAX Holdings, Inc. in a $880M transaction to form Real REMAX Group (NASDAQ: REAX), combining Real's ~$2.3B 2025 revenue AI-powered brokerage with RE/MAX's ~$155M 2025 Adjusted EBITDA, 180,000+ agents, and ~1.8M global transactions. Pro forma ownership will be 59% for Real shareholders and 41% for RE/MAX shareholders, assuming the midpoint of cash consideration. The deal includes stock-and-cash election for RE/MAX shareholders at 5.15 Real REMAX Group shares, subject to regulatory approvals, shareholder votes, and other closing conditions.

• ·RE/MAX operates in 120 countries and territories.
• ·Transaction consideration includes stock-and-cash election between 5.15 shares of Real REMAX Group (subject to 10-for-1 share consolidation of Real shares prior to closing).
• ·Pro forma 2025 financials represent combined Real and RE/MAX Holdings fiscal 2025 results.